The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The rate of tumor growth during treatment accurately predicts the FDA gold standard of overall survival [OS] in a broad range of malignancies.
 
Julia Wilkerson
No Relationships to Disclose
 
Krastan B. Blagoev
No Relationships to Disclose
 
Wilfred Donald Stein
No Relationships to Disclose
 
Elizabeth Hecht
No Relationships to Disclose
 
John A. Chabot
No Relationships to Disclose
 
Edward Espinal Dominguez
No Relationships to Disclose
 
Montserrat Blanco-Codesido
No Relationships to Disclose
 
Martin J. Murphy
No Relationships to Disclose
 
Antonio Tito Fojo
Consulting or Advisory Role - Cerulean Pharma
Patents, Royalties, Other Intellectual Property - Very small amount of royalties from the federal government from a long-standing agreement on taxol. This has now ended.
 
Susan Elaine Bates
Consulting or Advisory Role - Mundipharma
Travel, Accommodations, Expenses - AC Immune; Scandinavian Development Services